The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the European Academy of Neurology (EAN) have released a joint position statement on COVID-19 vaccination among patients with multiple sclerosis (MS).

It states that the COVID-19 vaccines currently available are safe for patients with MS. It also mentions that the vaccines provide the same protection to patients with MS as to the general population. However, there may be exceptions, such as patients taking the S1P modulator fingolimod and anti-CD20 drugs. Antibody responses have been found to be reduced in these patients. Presenting the statement at the 37th Congress of ECTRIMS 2021, held online, Mauricio Farez said that no specific contraindications for any COVID-19 vaccines in MS patients have been reported thus far… (Medscape)